逆行股动脉翻转为顺行技术及其对下肢血管造影后患者结局的影响
该回顾性队列研究比较了2018年10月1日至2020年9月30日期间342例下肢血管内手术中三种股总动脉入路技术:对侧逆行(RA)156例(45.6%)、同侧顺行(AA)82例(24.0%)和逆行翻转为顺行(RAFA)104例(30.4%)。AA组治疗性介入技术成功率最高(AA 98% vs RA 84% vs RAFA 91%,P=0.024),但总体并发症率也最高(AA 23% vs RA 10% vs RAFA 8.0%,P=0.025)。作者结论认为RAFA技术技术成功率高,且不增加传统股动脉入路的穿刺点并发症风险。
要点
- RAFA组技术成功率为91%,与AA组98%和RA组84%相比,AA组最高且差异有统计学意义(P=0.024)。
- AA组总体并发症率23%,高于RA组10%和RAFA组8.0%,差异有统计学意义(P=0.025)。
- AA组需要返回手术室的比值比最高(AA 17% vs RA 4.7% vs RAFA 4.5%,P=0.021)。
核心结论
- 作者认为,RAFA技术用于腹股沟下诊断和治疗性血管内治疗的技术成功率高,且与传统股动脉入路相比不增加穿刺点并发症风险。
研究设计与样本
- 回顾性队列研究,纳入2018年10月1日至2020年9月30日期间接受下肢诊断和治疗性血管造影的患者,共342例下肢血管内手术。
- 按股总动脉入路技术分为三组:对侧逆行(RA)156例(45.6%)、同侧顺行(AA)82例(24.0%)和逆行翻转为顺行(RAFA)104例(30.4%)。
主要发现
- 三组患者的平均年龄、性别和体重指数无显著差异(P>0.05)。
- RAFA组服用氯吡格雷(Plavix)的患者比例(46%)显著高于逆行组(24%)和顺行组(34%)(P<0.001)。
- RAFA组当前吸烟者比例较低(P=0.003),慢性阻塞性肺疾病比例较低(P=0.001)。
- AA组透视确认动脉穿刺的发生率较低(P=0.037)。
- 治疗性介入的技术成功率:AA组98%,RAFA组91%,RA组84%(P=0.024)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Common femoral artery access is a critical step in the endovascular treatment of peripheral artery disease. Traditionally, access is obtained either by a retrograde approach from the contralateral leg with an "up-and-over" aortic bifurcation technique, or in an antegrade fashion in the ipsilateral leg. Retrograde arterial access flipped antegrade in the ipsilateral femoral artery incorporates the technical ease of retrograde access (RA) with mechanical advantages of antegrade access (AA). There are limited studies directly comparing these techniques. The objective of this study is to describe and compare the different techniques for accessing the common femoral artery for diagnostic and therapeutic endovascular infrainguinal interventions. METHODS: This is a retrospective cohort study of patients undergoing lower extremity diagnostic and therapeutic angiography through either contralateral retrograde (RA), ipsilateral antegrade (AA), or retrograde femoral access flipped antegrade (RAFA) between October 1st, 2018, and September 30th, 2020. Outcomes measured were technical success, complications including hematoma, hemorrhage requiring transfusion, pseudoaneurysm, and repeat operative intervention. Differences in patient and treatment characteristics were analyzed using 2-sample t-test, Fisher's exact test and Chi-squared test. Multivariable logistic regression analysis was performed to identify associations with different access techniques and study outcomes. RESULTS: Of the 342 lower extremity endovascular procedures, 156 (45.6%) used RA access, 82 (24.0%) AA access, and 104 (30.4%) RAFA access. There were no significant differences in the mean age, gender, and body mass index between patients undergoing different access method cohorts (P > 0.05). The RAFA cohort had a significantly higher percentage of patients taking Plavix (46%) than retrograde (24%) and antegrade (34%) patients (P < 0.001). Patients undergoing RAFA access were less commonly active smokers (P = 0.003) or had chronic obstructive pulmonary disease (P = 0.001). Fluoroscopic confirmation of arterial puncture occurred less frequently in the AA cohort (P = 0.037). Technical success rate during therapeutic intervention was highest in the AA cohort (RA, 84%; AA, 98%; RAFA, 91%; P = 0.024). The AA cohort had the highest overall complication rate (RA, 10%; AA, 23% RAFA, 8.0%; P = 0.025) and the highest rate of requiring return to odds ratio (RA, 4.7%; AA, 17%; RAFA, 4.5%; P = 0.021). There were no significant differences in the incidence of hematoma, pseudoaneurysm, or death between all 3 cohorts (P > 0.05). CONCLUSION: The use of a RAFA technique for infrainguinal diagnostic and therapeutic endovascular therapy is not well studied. Our study demonstrates that this technique had a high rate of technical success without increasing the risk for access site complications compared to the traditional femoral artery access.
引用
- Lin AM, Strecker Z, Marecki H, et al. Retrograde Femoral Access Flipped Antegrade Technique and its Effect on Patient Outcomes Following Lower Extremity Angiography. Ann Vasc Surg. 2025. PMID: 40379093. doi:10.1016/j.avsg.2025.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。